Fibromyalgia continues to puzzle physicians. Its cause is unknown and there are only three drugs approved by the US Food and Drug Administration (FDA) to treat it. For reasons unknown, fibromyalgia impacts females and males in a 7:1 ratio, according to the centers for Disease Control and Prevention. Despite the challenges, researchers continue to examine where it stems from and how to make patients’ lives better.
There was a substantial amount of fibromyalgia research conducted in 2016. In addition to that, the editors at MD Magazine
attended conferences that highlighted the topic, including:
PAINWeek 2016 in Las Vegas, Nevada
2016 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (ACR 2016) in Washington, District of Columbia
Read on to catch up on the key fibromyalgia findings over the past year, and stay up-to-date with the MD Magazine fibromyalgia condition center
. Don’t forget to connect with us on Facebook
, and LinkedIn